NASSJ editor in chief Jonathan Grauer, MD, discusses the impact of COVID operating room restrictions with article authors Tobias Mattei, MD, and Justin Zhang, MD.

Access the article here.

Disclosures:

Grauer, Jonathan N.: Board of Directors: LSRS (Nonfinancial), NASS (Nonfinancial); Other: NASS (D).  

Mattei, Tobias Alecio: Nothing to Disclose  

Zhang, Justin: Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Ask the Experts: A Lifelong Learning Series

Nathaniel Brooks, MD

Disclosures:

Brooks, Nathaniel P.: Other: NASS (Nonfinancial, Minimally Invasive Procedure Section Chair).

Choi, Hoon : Nothing to Disclose

Jain, Nickul S.: Consulting: 4WEB (B), Centinel Spine (B), Spineart (B); Speaking and/or Teaching Arrangements: Relievant Medsystems (C).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Ask the Experts: A Lifelong Learning Series

Nathaniel Brooks, MD

Disclosures:

Brooks, Nathaniel P.: Other: NASS (Nonfinancial, Minimally Invasive Procedure Section Chair).

Hofstetter, Christoph P.: Consulting: Globus (C), Innovasis (B), Johnson & Johnson (B); Speaking and/or Teaching Arrangements: Johnson & Johnson (A), Joimax (D).

Choi, Hoon : Nothing to Disclose

Kim, Choll W.: Consulting: Elliquence (B), Globus (F), Spinal Elements (B), Stryker (B); Trips/Travel: Globus (D).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Ask the Experts: A Lifelong Learning Series

Joseph Schwab, MD

Disclosures:

Laufer, Ilya: Consulting: Brainlab (A), DePuy Synthes (B), Globus (B), Medtronic (C), Spine Wave (B).

Schwab, Joseph H.: Scientific Advisory Board: Chordoma Foundation (Nonfinancial); Speaking and/or Teaching Arrangements: AOSpine (Travel Expense Reimbursement, Outside 24-Month Requirement).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

NASSJ editor in chief Jonathan Grauer, MD, chats with author Roland Roelz about his article, "Implant in situ assembly for all-posterior lumbar vertebral column resection. Technical note."

Grauer, Jonathan N.: Board of Directors: LSRS (Nonfinancial), NASS (Nonfinancial); Other: NASS (D).

Roelz, Roland: Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

NASSJ editor in chief Jonathan Grauer, MD chats with author Eric Holder, MD about his paper, "Is there an association between lumbosacral epidural lipomatosis and lumbosacral epidural steroid injections? A comprehensive narrative literature review"

Disclosures:

Grauer, Jonathan N.: Board of Directors: LSRS (Nonfinancial), NASS (Nonfinancial); Other: NASS (D).

Holder, Eric  K.: Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

NASSJ editor in chief Jonathan Grauer, MD, discusses the value of NASSJ visual abstracts with Harold Moore, MD.

Disclosures:

Grauer, Jonathan N.: Board of Directors: LSRS (Nonfinancial), NASS (Nonfinancial); Other: NASS (D).

Moore, Harold : Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Author Shay Bess, MD, chats with NASSJ deputy editor Tobias Mattei, MD, about a recent NASSJ article "Opioid use prior to surgery is associated with worse preoperative and postoperative patient reported quality of life and decreased surgical cost effectiveness for symptomatic adult spine deformity; A matched cohort analysis."

Disclosures:

Bess, Shay: Consulting: K2M Stryker (B); Grants: DePuy Synthes (F, Paid directly to institution/employer), Globus Medical (E, Paid directly to institution/employer), Medtronic (F, Paid directly to institution/employer), NuVasive (F, Paid directly to institution/employer), SeaSpine (E, Paid directly to institution/employer), SI-BONE (D, Paid directly to institution/employer); Research Support (Staff and/or materials): Carlsmed  (E, Paid directly to institution/employer), International Spine Study Group Foundation (B); Royalties: NuVasive (B), Stryker (E).

Mattei, Tobias Alecio: Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Moderator Alex Michael, MD, chats with Richard Skolasky, ScD, about his recent SpineLine article on diversity and inclusion among NASS members. Dr. Skolasky is chair of NASS' Diversity Task Force.

Access the article here.

Disclosures:

Michael, Alex P: Nothing to Disclose  

Skolasky, Richard L.: Board of Directors: International Society For Quality Of Life Research (Nonfinancial), North American Spine Society (Nonfinancial, Governance Committee Chair, Research Program Management Chair, voting member); Other: International Society For Quality Of Life Research (B), International Society For Quality Of Life Research (Nonfinancial, Associate Editor for Quality of Life Research).  

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Ask the Experts: A Lifelong Learning Series 

Adam Doan, DC, DABNM

Disclosures:

Doan, Adam: Other: Nuvasive Clinical Services (Salary); Private Investments: Veridical RCM (D).

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, President (2019-2020)); Other: NuVasive Clinical Services (Salary, employment ended May 2021); Stock Ownership: NuVasive (less than 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+